These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17123769)

  • 21. Distal vein patch with an arteriovenous fistula: a viable option for the patient without autogenous conduit and severe distal occlusive disease.
    Neville RF; Dy B; Singh N; DeZee KJ
    J Vasc Surg; 2009 Jul; 50(1):83-8. PubMed ID: 19563955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regarding "Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery".
    Biancari F
    J Vasc Surg; 2007 Aug; 46(2):402; author reply 402-3. PubMed ID: 17664126
    [No Abstract]   [Full Text] [Related]  

  • 23. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery.
    Ucar HI; Tok M; Atalar E; Dogan OF; Oc M; Farsak B; Guvener M; Yilmaz M; Dogan R; Demircin M; Pasaoglu I
    Heart Surg Forum; 2007; 10(2):E131-5. PubMed ID: 17597037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions.
    Taylor SM; Kalbaugh CA; Blackhurst DW; Cass AL; Trent EA; Langan EM; Youkey JR
    J Vasc Surg; 2006 Oct; 44(4):747-55; discussion 755-6. PubMed ID: 16926083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
    Schanzer A; Hevelone N; Owens CD; Beckman JA; Belkin M; Conte MS
    J Vasc Surg; 2008 Apr; 47(4):774-781. PubMed ID: 18381138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between early postoperative C-reactive protein elevation and long-term postoperative major adverse cardiovascular and cerebral events in patients undergoing off-pump coronary artery bypass graft surgery: a retrospective study.
    Min JJ; Nam K; Kim TK; Kim HJ; Seo JH; Hwang HY; Kim KB; Murkin JM; Hong DM; Jeon Y
    Br J Anaesth; 2014 Sep; 113(3):391-401. PubMed ID: 24829443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
    Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
    J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The distaflo graft: a valid alternative to interposition vein?
    Fisher RK; Kirkpatrick UJ; How TV; Brennan JA; Gilling-Smith GL; Harris PL
    Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):235-9. PubMed ID: 12623335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative outcomes and amputation-free survival after lower extremity bypass surgery in California hospitals, 1996-1999, with follow-up through 2004.
    Feinglass J; Sohn MW; Rodriguez H; Martin GJ; Pearce WH
    J Vasc Surg; 2009 Oct; 50(4):776-783.e1. PubMed ID: 19595538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts.
    Jackson MR; Belott TP; Dickason T; Kaiser WJ; Modrall JG; Valentine RJ; Clagett GP
    J Vasc Surg; 2000 Sep; 32(3):498-504; 504-5. PubMed ID: 10957656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events.
    Nguyen LL; Lipsitz SR; Bandyk DF; Clowes AW; Moneta GL; Belkin M; Conte MS
    J Vasc Surg; 2006 Nov; 44(5):971-5; discussion 975-6. PubMed ID: 17098527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after interposition of vein grafts for arterial repair of extremity injuries in civilians.
    Klocker J; Bertoldi A; Benda B; Pellegrini L; Gorny O; Fraedrich G
    J Vasc Surg; 2014 Jun; 59(6):1633-7. PubMed ID: 24560243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material.
    Berglund J; Björck M; Elfström J;
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):412-8. PubMed ID: 15776397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass.
    Bellosta R; Natalini G; Luzzani L; Carugati C; Sarcina A
    Ann Vasc Surg; 2013 Feb; 27(2):218-24. PubMed ID: 23092735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.
    Owens CD; Rybicki FJ; Wake N; Schanzer A; Mitsouras D; Gerhard-Herman MD; Conte MS
    J Vasc Surg; 2008 Jun; 47(6):1235-42. PubMed ID: 18440187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, biochemical, and rheologic factors affecting the outcome of infrainguinal bypass grafting.
    Woodburn KR; Rumley A; Lowe GD; Love JG; Murray GD; Pollock JG
    J Vasc Surg; 1996 Oct; 24(4):639-46. PubMed ID: 8911413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased circulating plasminogen activator inhibitor-1 in patients with patent femoro-distal venous bypass.
    Peltonen S; Lassila R; Lepäntalo M
    Thromb Res; 1996 May; 82(4):369-77. PubMed ID: 8743732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease.
    Wahlgren CM; Sten-Linder M; Egberg N; Kalin B; Blohmé L; Swedenborg J
    Cardiovasc Intervent Radiol; 2006; 29(4):530-5. PubMed ID: 16729229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease.
    McDermott MM; Greenland P; Guralnik JM; Ferrucci L; Green D; Liu K; Criqui MH; Schneider JR; Chan C; Ridker P; Pearce WH; Martin G; Clark E; Taylor L
    Vasc Med; 2004 May; 9(2):107-15. PubMed ID: 15521700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.